Genoskin
FranceEntry
2025
Hold
1yr
Status
Active
Who owns Genoskin?
Genoskin is currently owned by OCCTE through OCCIDEV IMPACTS (2023 vintage), since 2025. Across its history, Genoskin has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2024 · present
Finorpa GestionActive
2024 · present(2yr) · Captech Sante · 2022 · Life Sciences VC
OCCTEActive
2025 · present(1yr) · OCCIDEV IMPACTS · 2023 · Impact
Grand Sud-Ouest CapitalActive
2025 · present(1yr) · GSO Innovation · 2018 · Growth
More from OCCIDEV IMPACTS
Other portfolio companies in the same fund.
More OCCTE portfolio companies
From the same investor, across funds.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Genoskin
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Genoskin?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Genoskin.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue